Multiple Sclerosis

Multiple sclerosis (MS) is a severe autoimmune disease of the central nervous system that affects the brain and spinal cord, causing problems with muscle movement, balance and vision.

Multiple Sclerosis (MS)

Multiple sclerosis (MS) is a neurodegenerative disorder that damages the nerves in the brain and spinal cord, leading to problems with muscle movement, balance and vision.

Anti-Myelin Antibodies in Multiple Sclerosis

Cognitive Impairment and Multiple Sclerosis

Multiple Sclerosis in Children

Multiple Sclerosis and Pregnancy

Multiple sclerosis and smoking

At-Home Physiotherapy Exercises for Multiple Sclerosis

Benign Multiple Sclerosis (MS)

Heat Intolerance in Multiple Sclerosis

Multiple Sclerosis Epidemiology

See more featured articles »

Epigenetics for Multiple Sclerosis

Early Signs of Multiple Sclerosis

Multiple Sclerosis and Women’s Health

Working Towards Earlier Diagnosis of Multiple Sclerosis

How is RRMS Different from PPMS and SPMS?

Multiple sclerosis and beta interferon

Primary Progressive Multiple Sclerosis (PPMS)

Optic Neuritis and Multiple Sclerosis

Relapsing-Remitting Multiple Sclerosis (RRMS)

Secondary Progressive Multiple Sclerosis (SPMS)

Types of Multiple Sclerosis (MS)

What Causes Multiple Sclerosis?

Remyelination Strategies for Multiple Sclerosis

Latest Multiple Sclerosis News and Research

Brain scans find no evidence of widespread inflammation in long COVID

A new brain imaging study has found no evidence of widespread brain inflammation in patients suffering from prolonged symptoms after COVID-19 infection. Instead, the most severe long COVID symptoms were associated with increased brain activity in regions involved in mood and emotion.

22 May 2026

New study shows how exercise hormone reduces multiple sclerosis symptoms

A new study offers clues as to why exercise can improve neurological symptoms in people with multiple sclerosis (MS).

21 May 2026

Smoking cessation may reduce dementia risk for people who avoid major weight gain

Quitting smoking may be associated with a lowered risk of dementia, especially for people who avoid major weight gain after quitting, according to a study published May 20, 2026, in Neurology, the medical journal of the American Academy of Neurology.

20 May 2026

Migraine with aura linked to higher ischemic stroke risk in middle-aged and older adults

Migraine with aura was associated with an increased risk of ischemic stroke in middle-aged and older people, according to a study published May 20, 2026, in Neurology Open Access, an official journal of the American Academy of Neurology.

20 May 2026

Preclinical models map genetic changes behind multiple sclerosis nerve damage

More than 1 million people across the United States live with multiple sclerosis (MS), a disease that affects the brain, optic nerves and spine.

18 May 2026

Research identifies significant spike in neurological disorders during the covid-19 pandemic

In 2021, neurological diseases affected 3.40 billion individuals worldwide, corresponding to 43.1 % of the global population. In China, rapid demographic shifts and lifestyle changes have contributed to a continued rise in the burden of stroke, dementia, and Parkinson's disease-a trend expected to persist.

15 May 2026

Identifying the methodology gap that prevents treatment of infection-triggered chronic diseases

Thousands of Americans develop chronic persistent symptoms-such as fatigue, cognitive difficulties ("brain fog"), and other debilitating issues-each year following acute infections from Lyme disease, COVID-19, and other pathogens. Efforts to identify causes and produce treatments have failed. However, 16 leading researchers think they know part of the problem: study design.

14 May 2026

Pregnancy not linked to increased myasthenia gravis flare-up risk

For female participants with myasthenia gravis, pregnancy is not associated with an increased risk of serious flare-ups of the disease, or new or worsening symptoms, according to a study published May 13, 2026, in Neurology, the medical journal of the American Academy of Neurology.

13 May 2026

CGRP inhibitors may reduce glaucoma risk among migraine patients

A type of drug used to prevent migraine may be associated with a reduced risk of glaucoma, according to a study published May 6, 2026, in Neurology®, the medical journal of the American Academy of Neurology.

6 May 2026

Global MS initiative opens applications for research data access

The International Progressive MS Alliance announces the MS Clinical and Imaging Data Resource (MS CIDR) is now accepting applications for data access.

4 May 2026

Glucose acts as a metabolic signal for myelin development

Researchers at the Advanced Science Research Center at the CUNY Graduate Center (CUNY ASRC) have uncovered a surprising link between low brain sugar levels and the development of myelin - the protective coating that allows nerve cells to communicate rapidly and efficiently.

30 Apr 2026

Virtual neurology visits match in-person care outcomes

For people who see a neurology clinician for the first time, a new study has found that being seen virtually vs. in-person made no difference in how soon they needed more care.

22 Apr 2026

Poor sleep linked to higher dementia risk in epilepsy

For people with epilepsy, getting poor sleep was associated with a higher risk of dementia compared to people without epilepsy, according to a study published April 22, 2026, in Neurology, the medical journal of the American Academy of Neurology.

22 Apr 2026

New antibody mechanism selectively suppresses harmful immune responses

The immune system is our frontline protection against infection, continually searching for and destroying unknown pathogens.

22 Apr 2026

Short-term and cumulative exposure to air pollution tied to increased migraine activity

Air pollution is associated with increased migraine activity, according to a study published on April 15, 2026, in Neurology, the medical journal of the American Academy of Neurology.

17 Apr 2026

Concerns rise over breast cancer risk and gender-based efficacy of Ocrevus

The US Food and Drug Administration (FDA) is reviewing a petition to revoke the approval of Roche's top-selling drug ocrelizumab (Ocrevus) for treating primary progressive multiple sclerosis (PPMS) - a form of MS thought to affect around 15 % of patients.

17 Apr 2026

Clearing amyloid beta shows no significant impact on dementia severity

Drugs that target amyloid beta proteins in the brain likely have no clinically meaningful positive effects, while increasing the risk of bleeding and swelling in the brain, a new Cochrane review has found.

16 Apr 2026

High-quality plant-based diets linked to lower dementia risk

Eating a higher quality plant-based diet is associated with a lower risk of Alzheimer's disease and other related dementias compared to eating a lower quality plant-based diet, according to a study published April 8, 2026, in Neurology, the medical journal of the American Academy of Neurology.

8 Apr 2026

Vitamin D levels in midlife tied to lower dementia risk marker

Having higher levels of vitamin D in the blood in middle age is associated with lower levels of tau protein in the brain, which is a sign of dementia, years later, according to a study published April 1, 2026, in Neurology Open Access, an official journal of the American Academy of Neurology.

1 Apr 2026

Mono infection associated with threefold higher multiple sclerosis risk

Having the disease infectious mononucleosis, often called mono, caused by the Epstein-Barr virus is associated with an increased risk of developing multiple sclerosis (MS), according to a study published on April 1, 2026, in Neurology® Open Access, an official journal of the American Academy of Neurology.

1 Apr 2026